From: Minimally Invasive Surgery for Colorectal Cancer
Trial | Ref. | Year of publication |
Year of registrasion |
Number of cases | Conversion rate | Postoperative complications |
5yDFS | 5yOS | |
---|---|---|---|---|---|---|---|---|---|
Barcelona | 2, 3 | 2004 | 1993-1998 | Lap | 105 | 11% | 12% | (Overall mortality 36%) | |
Op | 101 | - | 31%* | (Overall mortality 49%) | |||||
COST | 4, 5, 6 | 2007 | 1995-2001 | Lap | 435 | 21% | 21% | 80% | 86% |
Op | 428 | - | 20% | 81% | 85% | ||||
CLASICC | 7, 8, 9 | 2007 | 1996-2002 | Lap | 273 | 25% | 26% | 58% | 56% |
Op | 140 | - | 27% | 64% | 63% | ||||
COLOR | 10, 11, 12 | 2017 | 1997-2003 | Lap | 627 | 17% | 21% | 67% | 74% |
Op | 621 | - | 20% | 68% | 74% | ||||
JCOG0404 | 13, 14, 15, 16 | 2017 | 2004-2009 | Lap | 529 | 5.4% | 14% | 79% | 92% |
Op | 528 | - | 22%* | 80% | 90% |
From: Minimally Invasive Surgery for Colorectal Cancer
Trial | Ref. | Year of publication |
Year of registrasion |
Number of cases | Conversion rate | Postoperative complications |
Positive CRM | Local recurrence rate | DFS | OS | |
---|---|---|---|---|---|---|---|---|---|---|---|
CLASICC | 7, 8, 9 | 2007 | 1996-2002 | Lap | 235 | 34% | 40% | 12% | 11% | 53% | 60% |
Op | 128 | - | 37% | 6% | 9% | 52% | 53% | ||||
(5y) | |||||||||||
COLOR II | 27, 28 | 2015 | 2004-2010 | Lap | 699 | 17% | 40% | 10% | 5% | 75% | 87% |
Op | 345 | - | 37% | 10% | 5% | 71% | 84% | ||||
(3y) | |||||||||||
COREAN | 29, 30 | 2014 | 2006-2009 | Lap | 170 | 1.2% | 21% | 2.9% | 2.6% | 79% | 92% |
Op | 170 | - | 24% | 4.1% | 4.9% | 73% | 90% | ||||
(3y) | |||||||||||
ACOSOG Z6051 | 31, 32 | 2019 | 2008-2013 | Lap | 240 | 11% | 23% | 12% | 4.6% | 80% | - |
Op | 222 | - | 22% | 7.7% | 4.5% | 83% | - | ||||
(2y) | |||||||||||
ALaCaRT | 33, 34 | 2019 | 2010-2014 | Lap | 238 | 9% | 19% | 7% | 5.4% | 80% | - |
Op | 237 | - | 26% | 3% | 3.1% | 82% | - | ||||
(2y) | |||||||||||
ROLARR | 38, 39 | 2017 | 2011-2014 | Lap | 234 | 12.2% | 32% | 6.3% | - | - | - |
Robo | 237 | 8.1% | 33% | 5.1% | - | - | - |